Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Lopez-Rios

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
European Urology|March 27, 2019
Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary TractCora N Sternberg, Yohann Loriot, Nicholas James, et al.
Archives of Pathology & Laboratory Medicine|June 4, 2023
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic ApproachSusana Hernandez, Esther Conde, Aida Molero, et al.
European Urology Focus|June 5, 2024
Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract CarcinomaCora N Sternberg, Yohann Loriot, Ernest Choy, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB<sup>2</sup> harmonization project comparing three NGS panelsJavier Ramos-Paradas, Susana Hernández-Prieto, David Lora, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumabCarlos Gomez-Martin, Jose Carlos Plaza, Roberto Pazo-Cid, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2018
Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in EuropeCleo Keppens, John F Palma, Partha M Das, et al.
The Lancet Regional Health. Europe|March 13, 2024
Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countriesVincent D de Jager, Wim Timens, Arnaud Bayle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteriaMaximilian von Laffert, Arne Warth, Roland Penzel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2025
A Grading System for Resected Invasive Squamous Cell Carcinoma of the Lung: A Multi-Institutional Study by the IASLC Pathology CommitteeMari Mino-Kenudson, Sabina Berezowska, Yuko Minami, et al.
Archives of Pathology & Laboratory Medicine|September 12, 2019
Correlation of ROS1 Immunohistochemistry With <i>ROS1</i> Fusion Status Determined by Fluorescence In Situ HybridizationRichard S P Huang, Derek Smith, Catherine H Le, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
European Urology|March 27, 2019
Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary TractCora N Sternberg, Yohann Loriot, Nicholas James, et al.
Archives of Pathology & Laboratory Medicine|June 4, 2023
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic ApproachSusana Hernandez, Esther Conde, Aida Molero, et al.
European Urology Focus|June 5, 2024
Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract CarcinomaCora N Sternberg, Yohann Loriot, Ernest Choy, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB<sup>2</sup> harmonization project comparing three NGS panelsJavier Ramos-Paradas, Susana Hernández-Prieto, David Lora, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumabCarlos Gomez-Martin, Jose Carlos Plaza, Roberto Pazo-Cid, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2018
Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in EuropeCleo Keppens, John F Palma, Partha M Das, et al.
The Lancet Regional Health. Europe|March 13, 2024
Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countriesVincent D de Jager, Wim Timens, Arnaud Bayle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteriaMaximilian von Laffert, Arne Warth, Roland Penzel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2025
A Grading System for Resected Invasive Squamous Cell Carcinoma of the Lung: A Multi-Institutional Study by the IASLC Pathology CommitteeMari Mino-Kenudson, Sabina Berezowska, Yuko Minami, et al.
Archives of Pathology & Laboratory Medicine|September 12, 2019
Correlation of ROS1 Immunohistochemistry With <i>ROS1</i> Fusion Status Determined by Fluorescence In Situ HybridizationRichard S P Huang, Derek Smith, Catherine H Le, et al.
Pageof 7